SeaStar Medical Holding Corporation (ICU) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SeaStar Medical Holding Corporation (ICU) has a cash flow conversion efficiency ratio of -0.697x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.99 Million) by net assets ($4.30 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SeaStar Medical Holding Corporation market cap and net worth for the company's overall valuation and market capitalisation.
SeaStar Medical Holding Corporation - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how SeaStar Medical Holding Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
SeaStar Medical Holding Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SeaStar Medical Holding Corporation ranked by their cash flow conversion efficiency. Explore how high is SeaStar Medical Holding Corporation's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Principal Technologies Inc
V:PTEC
|
4.320x |
|
OpTeam S.A.
WAR:OPM
|
-0.102x |
|
KSG Agro SA
WAR:KSG
|
0.238x |
|
NSN Co. Ltd
KQ:031860
|
-0.143x |
|
COINSILIUM GROUP LTD
F:5CT
|
N/A |
|
Nukkleus Inc
NASDAQ:NUKK
|
0.033x |
|
Oceanic Beverages Co Inc
TW:1213
|
-0.090x |
|
Wetouch Technology Inc. Common Stock
NASDAQ:WETH
|
0.004x |
Annual Cash Flow Conversion Efficiency for SeaStar Medical Holding Corporation (2020–2025)
The table below shows the annual cash flow conversion efficiency of SeaStar Medical Holding Corporation from 2020 to 2025. View today's stock price for SeaStar Medical Holding Corporation for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $10.42 Million | $-13.60 Million | -1.306x | -117.81% |
| 2024-12-31 | $-2.18 Million | $-16.01 Million | 7.333x | +888.85% |
| 2023-12-31 | $-13.87 Million | $-10.29 Million | 0.742x | +97.53% |
| 2022-12-31 | $-20.76 Million | $-7.79 Million | 0.375x | -79.33% |
| 2021-12-31 | $-2.82 Million | $-5.11 Million | 1.816x | +2233.07% |
| 2020-12-31 | $-71.58 Million | $-5.57 Million | 0.078x | -- |
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperi… Read more